178 related articles for article (PubMed ID: 23421821)
1. Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.
Contino F; Mazzarella C; Ferro A; Lo Presti M; Roz E; Lupo C; Perconti G; Giallongo A; Feo S
BMC Cancer; 2013 Feb; 13():81. PubMed ID: 23421821
[TBL] [Abstract][Full Text] [Related]
2. Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.
Lo Presti M; Ferro A; Contino F; Mazzarella C; Sbacchi S; Roz E; Lupo C; Perconti G; Giallongo A; Migliorini P; Marrazzo A; Feo S
PLoS One; 2010 Sep; 5(9):e12961. PubMed ID: 20886042
[TBL] [Abstract][Full Text] [Related]
3. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
Mrhalová M; Kodet R; Kalinová M; Hilská I
Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
Scott GK; Marden C; Xu F; Kirk L; Benz CC
Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
6. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
7. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
[TBL] [Abstract][Full Text] [Related]
8. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
[TBL] [Abstract][Full Text] [Related]
9. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
[TBL] [Abstract][Full Text] [Related]
10. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.
Xu X; Jin H; Liu Y; Liu L; Wu Q; Guo Y; Yu L; Liu Z; Zhang T; Zhang X; Dong X; Quan C
Diagn Pathol; 2012 Mar; 7():33. PubMed ID: 22455563
[TBL] [Abstract][Full Text] [Related]
11. Ets regulation of the erbB2 promoter.
Scott GK; Chang CH; Erny KM; Xu F; Fredericks WJ; Rauscher FJ; Thor AD; Benz CC
Oncogene; 2000 Dec; 19(55):6490-502. PubMed ID: 11175365
[TBL] [Abstract][Full Text] [Related]
12. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.
Vernimmen D; Gueders M; Pisvin S; Delvenne P; Winkler R
Br J Cancer; 2003 Sep; 89(5):899-906. PubMed ID: 12942124
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.
Bianco C; Castro NP; Baraty C; Rollman K; Held N; Rangel MC; Karasawa H; Gonzales M; Strizzi L; Salomon DS
J Cell Physiol; 2013 Jun; 228(6):1174-88. PubMed ID: 23129342
[TBL] [Abstract][Full Text] [Related]
15. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma.
Couturier J; Vincent-Salomon A; Nicolas A; Beuzeboc P; Mouret E; Zafrani B; Sastre-Garau X
Mod Pathol; 2000 Nov; 13(11):1238-43. PubMed ID: 11106082
[TBL] [Abstract][Full Text] [Related]
16. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).
Feo S; Arcuri D; Piddini E; Passantino R; Giallongo A
FEBS Lett; 2000 May; 473(1):47-52. PubMed ID: 10802057
[TBL] [Abstract][Full Text] [Related]
17. Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma.
Cao L; Basudan A; Sikora MJ; Bahreini A; Tasdemir N; Levine KM; Jankowitz RC; McAuliffe PF; Dabbs D; Haupt S; Haupt Y; Lucas PC; Lee AV; Oesterreich S; Atkinson JM
Cancer Lett; 2019 Oct; 461():21-30. PubMed ID: 31229512
[TBL] [Abstract][Full Text] [Related]
18. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
[TBL] [Abstract][Full Text] [Related]
19. Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.
Ghosh AK; Steele R; Ray RB
Mol Cell Biol; 1999 Apr; 19(4):2880-6. PubMed ID: 10082554
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
Toya H; Oyama T; Ohwada S; Togo N; Sakamoto I; Horiguchi J; Koibuchi Y; Adachi S; Jigami T; Nakajima T; Akiyama T
Cancer Sci; 2007 Apr; 98(4):484-90. PubMed ID: 17309600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
